Metformin impairs Rho GTPase signaling to induce apoptosis in neuroblastoma cells and inhibits growth of tumors in the xenograft mouse model of neuroblastoma.

Metformin impairs Rho GTPase signaling to induce apoptosis in neuroblastoma cells and inhibits growth of tumors in the xenograft mouse model of neuroblastoma.
复制标题

DOI:
10.18632/oncotarget.2606
复制
发表时间:
2014-11-30
期刊:
影响因子:
--
通讯作者:
Singh US
Singh US
中科院分区:
其他
文献类型:
--
作者:
Kumar A;Al-Sammarraie N;DiPette DJ;Singh US

文献摘要

参考文献

被引文献

相似文献

Metformin has been shown to inhibit tumor growth in xenograft rodent models of adult cancers, and various human clinical trials are in progress. However, the precise molecular mechanisms of metformin action are largely unknown. In the present study we examined the anti-tumor activity of metformin against neuroblastoma, and determined the underlying signaling mechanisms. Using human neuroblastoma xenograft mice, we demonstrated that oral administration of metformin (100 and 250 mg/kg body weight) significantly inhibited the growth of tumors. The interference of metformin in spheroid formation further confirmed the anti-tumor activity of metformin. In tumors, the activation of Rac1 (GTP-Rac1) and Cdc42 (GTP-Cdc42) was increased while RhoA activation (GTP-RhoA) was decreased by metformin. It also induced phosphorylation of JNK and inhibited the phosphorylation of ERK1/2 without affecting p38 MAP Kinase. Infection of cells by adenoviruses expressing dominant negative Rac1 (Rac1-N17), Cdc42 (Cdc42-N17) or constitutively active RhoA (RhoA-V14), or incubation of cells with pharmacological inhibitors of Rac1 (NSC23766) or Cdc42 (ML141) significantly protected neuroblastoma cells from metformin-induced apoptosis. Additionally, inhibition of JNK activity along with Rac1 or Cdc42 attenuated cytotoxic effects of metformin. These studies demonstrated that metformin impairs Rho GTPases signaling to induce apoptosis via JNK pathway.
二甲双胍通过下调 Stat3 信号促进食管鳞状细胞癌自噬和凋亡
DOI: 10.1038/cddis.2014.59
发表时间: 2014-02-27
影响因子: 9
作者:
通讯作者: --
DOI: 10.1371/journal.pone.0096343
发表时间: 2014
期刊: PloS one
影响因子: 3.7
作者:
Kumar A;Fan D;Dipette DJ;Singh US
通讯作者: Singh US
DOI: 10.2337/diabetes.54.7.2179
发表时间: 2005-07-01
期刊: DIABETES
影响因子: 7.7
作者:
Detaille, D;Guigas, B;Leverve, X
通讯作者: Leverve, X
DOI: 10.1200/jco.2009.19.6410
发表时间: 2009-07-10
影响因子: 45.3
作者:
Jiralerspong, Sao;Palla, Shana L.;Gonzalez-Angulo, Ana M.
通讯作者: Gonzalez-Angulo, Ana M.
DOI: 10.1111/j.1530-0277.2010.01166.x
发表时间: 2010-05-01
影响因子: 3.2
作者:
Kumar, Ambrish;Singh, Chandra K.;Singh, Ugra S.
通讯作者: Singh, Ugra S.